Capital raised by Aer Therapeutics
1 Form D filing · first filed Jan 2025 · Raleigh, NC
Chairman of the Board of Directors
Signatory on Aer Therapeutics's Form D filings · $5.0M raised across 1
Thomas Mathers is on file as Chairman of the Board of Directors at Aer Therapeutics in Raleigh, NC. Aer Therapeutics has 1 Form D filing on record, $5.0M raised in total. Thomas Mathers appears as a signatory on the company's filings.
AER-01 is a lead therapeutic candidate designed to dissolve mucus plugs in the airways of patients with severe respiratory diseases. Developed through extensive academic collaborations, it is an inhaled thiol-saccharide mucolytic agent intended to improve lung function and ease breathing difficulties.
